COVID-19 Vaccination for People with Disabilities Product: — Science Table Health Status Public Health & Implementation Vaccine Vaccines & Immunity Vulnerable Groups Vulnerable Sub-populations covid19-sciencetable.ca Last Updated: June 15, 2021
Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines Product: — Science Table Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity covid19-sciencetable.ca Last Updated: May 11, 2021
Understanding Long COVID-19 Product: — Evidence Synthesis Network Long Covid Signs & Symptoms esnetwork.ca Last Updated: May 7, 2021
Long COVID‑19 Clinics Product: — Evidence Synthesis Network Long Covid Regulation & Policy Workplace Regulations esnetwork.ca Last Updated: April 27, 2021
Understanding Long COVID-19 Product: — Evidence Synthesis Network Long Covid Signs & Symptoms esnetwork.ca Last Updated: April 7, 2021
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 Product: — Science Table Drug Interventions Infectious Diseases & Clinical Care Treatments covid19-sciencetable.ca Last Updated: February 25, 2021
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID‐19 Product: — Cochrane Library Hospital Care Most Common Signs & Symptoms Signs & Symptoms Urgent Care www.cochranelibrary.com Last Updated: February 23, 2021 Also available in Français
COVID-19 Outcomes For Priority Populations And Settings Product: — Evidence Synthesis Network Health Inequities Low SES Vulnerable Groups Vulnerable Sub-populations esnetwork.ca Last Updated: February 22, 2021